Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile

Ann Rheum Dis. 2007 Jan;66(1):136-7. doi: 10.1136/ard.2006.056804.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / immunology
  • Behcet Syndrome / physiopathology
  • Cytokines / analysis*
  • Cytokines / blood
  • Cytokines / cerebrospinal fluid
  • Female
  • Humans
  • Infliximab
  • Magnetic Resonance Imaging*
  • Transcranial Magnetic Stimulation*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Cytokines
  • Tumor Necrosis Factor-alpha
  • Infliximab